Novartis AG - Payout Ratio History
Payout ratio history for stock NVS (Novartis AG).
| Date | Payout ratio |
|---|---|
| April 2024 | 92.13% |
| March 2024 | 92.13% |
| February 2024 | 89.87% |
| January 2024 | 47.91% |
| December 2023 | 47.93% |
| November 2023 | 48.46% |
| October 2023 | 45.84% |
| September 2023 | 44.40% |
| August 2023 | 44.76% |
| July 2023 | 45.80% |
| June 2023 | 45.92% |
| May 2023 | 47.22% |
| April 2023 | 47.22% |
| March 2023 | 47.48% |
| February 2023 | 51.57% |
| January 2023 | 52.21% |
| December 2022 | 49.44% |
| November 2022 | 51.33% |
| October 2022 | 50.33% |
| September 2022 | 49.44% |
| August 2022 | 50.41% |
| July 2022 | 50.41% |
| June 2022 | 50.41% |
| May 2022 | 50.41% |
| April 2022 | 49.93% |
| March 2022 | 50.72% |
| February 2022 | 50.72% |
| January 2022 | 48.32% |
| December 2021 | 48.32% |
| October 2021 | 81.19% |
| September 2021 | 85.74% |
| August 2021 | 85.74% |
| July 2021 | 97.35% |
| June 2021 | 97.35% |
| May 2021 | 92.19% |
| April 2021 | 95.97% |
| March 2021 | 86.42% |
| February 2021 | 86.42% |
| January 2021 | 271.61% |
| December 2020 | 253.05% |
| November 2020 | 90.42% |
| October 2020 | 89.37% |
| September 2020 | 89.37% |
| August 2020 | 89.37% |
| July 2020 | 55.48% |
| June 2020 | 55.48% |
| May 2020 | 52.68% |
| April 2020 | 52.68% |
| March 2020 | 52.68% |
| February 2020 | 52.68% |
| January 2020 | 52.68% |
| December 2019 | 52.68% |
| November 2019 | 52.68% |
| October 2019 | 52.68% |
| September 2019 | 52.68% |
| August 2019 | 52.68% |
| July 2019 | 52.68% |
| June 2019 | 52.68% |
| May 2019 | 52.68% |
| April 2019 | 52.68% |
| March 2019 | 54.58% |
| February 2019 | 54.58% |
| December 2018 | 51.40% |
| December 2017 | 96.70% |
| December 2016 | 95.70% |
| December 2015 | 77.70% |
| December 2014 | 66% |
| December 2013 | 66.80% |
| December 2012 | 63.80% |
| December 2011 | 55.70% |
| December 2010 | 45.70% |
| December 2009 | 46.50% |
| December 2008 | 43.10% |
| December 2007 | 54.71% |
| December 2006 | 35.21% |
| December 2005 | 33.39% |
| December 2004 | 36.22% |
| December 2003 | 39.85% |
| December 2002 | 38.66% |
| December 2001 | 30.68% |
| December 2000 | 25.57% |
NVS
List: Challengers
Price: $92.57
Dividend Yield: 0.04%
Forward Dividend Yield: 4.08%
Payout Ratio: 92.13%
Dividend Per Share: 3.78 USD
Earnings Per Share: 4.10 USD
P/E Ratio: 24.72
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 1.7 million
Ebitda: 2.5 billionMarket Capitalization: 195.8 billion
Average Dividend Frequency: 1
Years Paying Dividends: 28
DGR3: 4.59%
DGR5: 5.70%
DGR10: 4.54%
DGR20: 9.41%